Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: A dose-response study of enteral vancomycin to reduce absolute carriage and infection

Anaesthesia and Intensive Care

Volumn 33, Issue 3, 2005, Pages 361-372

  Viviani, M ^a   van Saene, H K F ^b   Dezzoni, R ^a   Silvestri, L ^c   di Lenarda, R ^d   Berlot, G ^a   Gullo, A ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c Ospedaliero Gorizia ^*  (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Intensive care, infection: methicillin resistant Staphylococcus aureus, absolute carriage exposure, enteral vancomycin, transmission, vancomycin resistant enterococci

Indexed keywords

VANCOMYCIN;

ABSOLUTE CARRIAGE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; BACTERIUM CULTURE; DISEASE CARRIER; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GEL; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL PARAMETERS; STAPHYLOCOCCUS INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 21344454480     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0503300312     Document Type: Article

References (55)

1. Coello R, Glynn JR, Gaspar C, Picazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 1997; 37:39-46.
2. de la Cal MA, Cerda E, Garcia-Hierro P et al. Pneumonia in patients with severe burns: a classification according to the concept of the carrier state. Chest 2001; 119:1160-1165.
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-59.
4. Liberati A, D'Amico R, Pifferi S et al. Antibiotic prophylaxis reduces respiratory tract infections and crude mortality in adults receiving intensive care. Cochrane Database Syst Rev 2004; 1: CD 000 22.
5. de Jonge E, Schultz MJ, Spanjaard L et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized controlled trial. Lancet 2003; 362:1011-1016.
6. Baxby D, van Saene HKF, Stoutenbeek CP, Zandstra DF. Selective decontamination of the digestive tract: 13 years on, what it is and what it is not. Intensive Care Med 1996; 22:699-706.
7. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French study group on selective decontamination of the digestive tract. N Engl J Med 1992; 326:594-599.
8. Hammond JMJ, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992; 340:5-9.
9. Ferrer M, Torres A, Gonzalez J et al. Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 1994; 120:389-395.
10. Wiener J, Itokazu G, Nathan C, Kabins SA, Weinstein RA. A randomized, double-blind, placebo-controlled trial of selective decontamination in a medical-surgical intensive care unit. Clin Infect Dis 1995; 20:861-867.
11. Lingnau W, Berger J, Javorsky F, Lejeune P, Mutz N, Benzer H. Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 1997; 42:687-694.
12. Verwaest C, Verhaegen J, Ferdinande P et al. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 1997; 25:63-71.
13. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia: a randomized, placebo-controlled, double-blind clinical trial. JAMA 1991; 265:2704-2710.
14. Krueger WA, Lenhart FP, Neeser G et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2002; 166:1029-1037.
15. Bergmans DCJJ, Bonten MJM, Gaillard CA et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001; 164:382-388.
16. Korinek AM, Laisne MJ, Nicolas MH, Raskine L, Deroin V, Sanson-Lepors MJ. Selective decontamination of the digestive tract in neurosurgical intensive care units patients: a double-blind, randomized, placebo controlled study. Crit Care Med 1993; 21:1466-1473.
17. Schardey HM, Joosten U, Finke U et al. The prevention of anastomotic leakage after total gastrectomy with local decontamination: a prospective, randomized, double-blind, placebo-controlled multicentre trial. Ann Surg 1997; 225:172-180.
18. Gaussorgues Ph, Salord F, Sirodot M et al. Nosocomial bacteremia in patients under mechanical ventilation and receiving beta-inotropic drugs: efficacy of digestive decontamination. Réan Soins Intens Med Urg 1991; 7:169-174.
19. Wenzel RP, Reagan DR, Bertino JS, Baron EJ, Arias K. Methicillin-resistant Staphylococcus aureus outbreak: A consensus panel's definition and management guidelines. Am J Infect Control 1998; 26:102-110.
20. McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Intern Med 1962; 110:847-855.
21. Feinstein AR. The role of the manoeuvre in cause-effect research. In: Clinical Epidemiology (Feinstein AR ed), Philadelphia, WB Saunders 1985; 191-214.
22. Leonard EM, van Saene HKF, Shears P, Walker J, Tam PK. Pathogenesis of colonization and infection in a neonatal surgical unit. Crit Care Med 1990; 18:264-269.
23. van Saene HKF, Taylor N, Donnell SC et al. Gut overgrowth with abnormal flora: the missing link in parenteral nutrition-related sepsis in surgical neonates. Eur J Clin Nutrit 2003; 57: 548-553.
24. A'Court CH, Garrard CS, Crook D et al. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. QJ Med 1993; 86:635-638.
25. Sarginson RE, Taylor N, van Saene HKF. Glossary of terms and definitions. Curr Anaesth Crit Care 2001; 12:2-5.
26. Merrer J, Santoli F, Appéré-De Vecchi C, Tran B, De Jonghe B, Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000; 21:718-723.
27. Damjanovic V, Connolly CM, van Saene HKF et al. Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect 1993; 24: 245-259.
28. Silvestri L, Milanese M, Oblach L et al. Enteral vancomycin to control methicillin resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 2002; 30: 391-399.
29. de la Cal MA, Cerda E, van Saene HKF et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 2004; 56:175-183.
30. British Society for Antimicrobial Chemotherapy and Hospital Infection Society. Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998; 39:253-290.
31. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27:543-550.
32. Coello R, Jiménez J, García M et al. Prospective study of infection, colonization and carriage of methicillin resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994; 13:74-81.
33. Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995; 29:87-106.
34. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43:1412-1416.
35. Jordan HV, De Paola PF. Effect of a topically applied 3% vancomycin gel on Streptococcus mutans on different tooth surfaces. J Dent Res 1974; 53:115-120.
36. Silvestri L, van Saene HKF, Milanese M et al. Prevention of MSRA pneumonia by oral vancomycin decontamination: a randomized trial. Eur Respir J. 2004; 23:921-926.
37. Ledingham I, Alcock SR, Eastaway AT, McDonald JC, McKay IC, Ramsay G. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1988; 1:785-790.
38. Taylor ME, Oppenheim BA. Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 1991; 17:271-278.
39. Maraha B, van Halteren J, Verzijl JM, Wintermans RG, Buiting AG. Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin. Clin Microbiol Infect 2002; 8:671-675.
40. Agusti C, Pujol M, Argerich MJ et al. Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. J Antimicrob Chemother 2002; 49:205-208.
41. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16:105-113.
42. Chang S, Sievert DM, Hageman JC et al. Infection with vancomycin-resistant Staphylococcus aureus containing the van A resistance gene. N Engl J Med 2003; 348:1342-1347.
43. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273:214-219.
44. Torell E, Cars O, Olson-Liljequist B, Hoffman BM, Lindback J, Burman LG. Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and non-hospitalized individuals in Sweden. J Clin Microbiol 1999; 37: 3509-3513.
45. Venditti M, Tarasi A, Visco Comandini U et al. Enterococcal septicemia in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1993; 12:241-247.
46. Manhold C, von Rolbicki U, Brase R et al. Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study. Intensive Care Med 1998; 24:1327-1330.
47. Geraci JE, Heilman FR, Nicols DR et al. Some laboratory and clinical experience with a new antibiotic, vancomycin. Proc Staff Meet Mayo Clin 1956; 31:546-582.
48. Tedesco F, Markham R, Gurwith M, Christie D, Bartlett JG. Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 1978; 2:226-228.
49. Guidelines for the management of adults with hospital-acquired, ventilator-associated and heathcare-associated pneumonia, Am J Respir Crit Care Med 2005; 171:388-416.
50. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474.
51. Morris JG, Shay DK, Hebden JN et al. Enterococci resistant to multiple antimicrobial agents including vancomycin. Ann Intern Med 1995; 123:250-259.
52. Guerin F, Buu-Hoi A, Mainardi JL et al. Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J Clin Microbiol 2000; 38:2985-2988.
53. Chadwick PR, Chadwick CD, Oppenheim BA. Report of a meeting on the epidemiology and control of glycopeptide-resistant enterocoeci. J Hosp Infect 1996; 33:83-92.
54. Siu YK, Ng PC, Fung SCK et al. Double blind, randomised, placebo-controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1998; 79: F105-F109.
55. Bhorade SM, Christenson J, Pohlman AS, Arnow PM, Hall JB. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999; 115:1085-1091.